Richard M. Bergenstal, MD, executive director
Richard Bergenstal, MD, is an adult endocrinologist and executive director of IDC. He is also clinical professor in the Department of Medicine at the University of Minnesota Medical School. In 2010, he served as president, science and medicine, of the American Diabetes Association (ADA), and in 2007, he was named ADA’s Outstanding Physician Clinician of the Year.
Dr. Bergenstal received his MD and endocrine training from the University of Chicago where he was assistant professor of medicine before joining IDC in 1983. His clinical research has focused on glucose control and diabetes complications. He serves as principal investigator of three National Institutes of Health trials – the Diabetes Control and Complications Trial (DCCT) in type 1 diabetes, and the Action to Control Cardiovascular Risk in Diabetes (ACCORD), and Glycemic Reduction Approaches in Diabetes (GRADE) studies in late and early onset type 2 diabetes. His clinical work focuses on optimizing patient-centered team care and the appropriate use of glucose monitoring and insulin therapy.
Glenn Matfin, MD, medical director
Glenn Matfin, MD, is an adult endocrinologist and the center’s medical director. Before joining IDC, he was senior staff physician at Joslin Diabetes Center and clinical associate professor at New York University. He received his MD and training from the University of Leeds, in the United Kingdom. In his fellowship, he worked for renowned diabetes expert Professor Sir George Alberti, which sparked an interest in diabetes.
After moving to the United States, Dr. Matfin worked with the Pima Indians in Phoenix, Arizona for the National Institutes of Health. He has designed more than 100 clinical trials involving more than 100,000 subjects, and has been involved in professional education programs for health care providers in the United States and globally.
Roger S. Mazze, PhD, professor and head of WHO Collaborating Center
Roger Mazze, PhD, is head of the International Diabetes Center-Mayo Clinic World Health Organization (WHO) Collaborating Center in Diabetes for Diabetes Education, Translation and Computer Technology. He is also professor in the Department of Family Medicine at the University of Minnesota Medical School as well as at Nanjing Medical University. He received a PhD from the University of Illinois and was a Lemberg Center Fellow at Brandeis University, as well as professor of Epidemiology and Social Medicine at Albert Einstein College of Medicine.
As principal author of the Staged Diabetes Management (SDM) program and a member of the SDM implementation team, he and the team have introduced SDM to more than 400 clinical sites throughout the United States and many other countries. He has been an innovator in the analysis and clinical use of glucose monitoring data to improve diabetes care. In 2011, Dr. Mazze received a five-year grant to prepare 500 physicians in China as diabetes experts in care, research and education under the auspices of The Ministry of Health.
Joan Bissen